中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2015年
15期
112-114
,共3页
拉贝洛尔%妊娠高血压%疗效
拉貝洛爾%妊娠高血壓%療效
랍패락이%임신고혈압%료효
Labetalol%Pregnancy-induced hypertension%Curative effect
目的:探讨拉贝洛尔治疗妊娠高血压的临床效果及对分娩结局的影响。方法选取我院收治的120例妊娠高血压患者随机分为观察组和对照组,对照组采用常规方法治疗,观察组在对照组基础上加用拉贝洛尔治疗,比较两组患者治疗效果及对分娩结局影响。结果观察组治疗后收缩压和舒张压均低于对照组,两组比较差异有统计学意义(P<0.05);观察组不良妊娠结局发生率为6.67%,明显低于对照组21.67%的发生率,两组比较差异有统计学意义(P<0.05);观察组患者分娩后新生儿1、5min Apgar评分均高于对照组,两组比较有统计学意义(P<0.05)。结论拉贝洛尔治疗妊娠高血压可有效降低血压,减少不良妊娠结局发生率,提高胎儿出生质量,具有显著临床治疗效果,值得在临床中推广应用。
目的:探討拉貝洛爾治療妊娠高血壓的臨床效果及對分娩結跼的影響。方法選取我院收治的120例妊娠高血壓患者隨機分為觀察組和對照組,對照組採用常規方法治療,觀察組在對照組基礎上加用拉貝洛爾治療,比較兩組患者治療效果及對分娩結跼影響。結果觀察組治療後收縮壓和舒張壓均低于對照組,兩組比較差異有統計學意義(P<0.05);觀察組不良妊娠結跼髮生率為6.67%,明顯低于對照組21.67%的髮生率,兩組比較差異有統計學意義(P<0.05);觀察組患者分娩後新生兒1、5min Apgar評分均高于對照組,兩組比較有統計學意義(P<0.05)。結論拉貝洛爾治療妊娠高血壓可有效降低血壓,減少不良妊娠結跼髮生率,提高胎兒齣生質量,具有顯著臨床治療效果,值得在臨床中推廣應用。
목적:탐토랍패락이치료임신고혈압적림상효과급대분면결국적영향。방법선취아원수치적120례임신고혈압환자수궤분위관찰조화대조조,대조조채용상규방법치료,관찰조재대조조기출상가용랍패락이치료,비교량조환자치료효과급대분면결국영향。결과관찰조치료후수축압화서장압균저우대조조,량조비교차이유통계학의의(P<0.05);관찰조불량임신결국발생솔위6.67%,명현저우대조조21.67%적발생솔,량조비교차이유통계학의의(P<0.05);관찰조환자분면후신생인1、5min Apgar평분균고우대조조,량조비교유통계학의의(P<0.05)。결론랍패락이치료임신고혈압가유효강저혈압,감소불량임신결국발생솔,제고태인출생질량,구유현저림상치료효과,치득재림상중추엄응용。
Objective To explore the clinical effect of labetalol in the treatment of patients with pregnancy-induced hypertension and its influence on delivery outcome.Methods120 patients with pregnancy-induced hypertension who were admitted to our hospital were randomly divided into observation group and control group. The control group was treated with conventional treatment, and the observation group was further treated with labetalol. The curative effect and its influence on delivery outcome of two groups were compared.Results Systolic pressure and diastolic pressure of observation group after treatment were both lower than those of control group, and the difference was statistically significant (P<0.05). Incidence rate of adverse pregnancy outcomes of observation group was 6.67%, which was significantly lower than 21.67% of control group, and the difference was statistically significant (P<0.05). The neonates' Apgar scores at 1min and 5mins of observation group were both higher than those of control group, and the difference was statistically significant(P<0.05).Conclusion Labetalol in the treatment of patients with pregnancy-induced hypertension can effectively lower blood pressure and incidence rate of adverse pregnancy outcome to improve neonates' quality, which has significant clinical effect and is worthy of clinical promotion and application.